STOK · Insider trading · 13F holders · Congress trades
Stoke Therapeutics, Inc. (STOK)
Who is buying and selling STOK: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 18
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $1.1M
- Congress trades, 12 months
- 0
STOK at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 3 STOK insiders filed 7 sales worth $1.1M on SEC Form 4, and no open-market purchases; 4 of the sales were pre-planned under Rule 10b5-1.
- 18 13F filers hold STOK among their 50 largest positions, worth $899.3M combined, including Oleg Nodelman, James Flynn and Julian and Felix Baker. The biggest bets by portfolio weight are Lynx1 Capital Management LP (15.3%), Redmile Group, LLC (8.7%) and Troluce Capital Advisors LLC (6.1%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
- No member of Congress has disclosed a trade in STOK.
- STOK last closed at $26.35 on Oct 29, 2026.
STOK insider trading
Between Aug 1, 2026 and Oct 29, 2026, 3 STOK insiders filed 7 sales worth $1.1M on SEC Form 4, and no open-market purchases; 4 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sale10b5-1 | 1,051 | $26.16 | $27K | SEC |
| Oct 2, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sale10b5-1 | 627 | $26.33 | $17K | SEC |
| Sep 3, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sale10b5-1 | 5,545 | $30.67 | $170K | SEC |
| Aug 18, 2026 | Kaye Edward M. MD | Director | Sale | 12,567 | $32.03 | $403K | SEC |
| Aug 18, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sale | 4,767 | $32.03 | $153K | SEC |
| Aug 18, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sale | 2,861 | $32.03 | $92K | SEC |
| Aug 5, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sale10b5-1 | 7,176 | $29.04 | $208K | SEC |
Who owns STOK? Hedge funds and superinvestors
18 13F filers hold STOK among their 50 largest positions, worth $899.3M combined, including Oleg Nodelman, James Flynn and Julian and Felix Baker. The biggest bets by portfolio weight are Lynx1 Capital Management LP (15.3%), Redmile Group, LLC (8.7%) and Troluce Capital Advisors LLC (6.1%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
Superinvestors holding STOK: Oleg Nodelman 1.2% · James Flynn 0.7% · Julian and Felix Baker 0.5%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Rtw Investments, LPHedge fund | 1.6% | $184.0M | 5,623,525 | +0.0% shares | Q2 2026 |
| Lynx1 Capital Management LPHedge fund | 15.3% | $132.1M | 4,038,404 | -15.2% shares | Q2 2026 |
| Redmile Group, LLCHedge fund | 8.7% | $129.1M | 3,945,920 | -5.2% shares | Q2 2026 |
| Julian and Felix BakerHedge fund | 0.5% | $109.2M | 3,336,697 | +0.0% shares | Q2 2026 |
| Bvf Inc/ilInvestment manager | 2.1% | $83.4M | 2,547,557 | +0.0% shares | Q2 2026 |
| Siren, L.L.C.Investment manager | 1.3% | $65.3M | 1,995,347 | +0.0% shares | Q2 2026 |
| James FlynnHedge fund | 0.7% | $59.7M | 1,823,500 | +0.0% shares | Q2 2026 |
| Oleg NodelmanHedge fund | 1.2% | $24.0M | 735,000 | +635.0% shares | Q2 2026 |
| Mpm Bioimpact LLCHedge fund | 1.4% | $23.7M | 723,314 | -5.7% shares | Q2 2026 |
| Opaleye Management Inc.Hedge fund | 2.1% | $22.9M | 700,000 | +0.0% shares | Q2 2026 |
| Troluce Capital Advisors LLCHedge fund | 6.1% | $16.2M | 496,416 | -24.0% shares | Q2 2026 |
| Granahan Investment Management, LLCAsset manager | 0.5% | $15.1M | 461,608 | — | Q2 2026 |
| Parkman Healthcare Partners LLCHedge fund | 1.2% | $11.6M | 355,443 | +5.6% shares | Q2 2026 |
| Tang Capital Management LLCHedge fund | 0.4% | $9.8M | 300,000 | -40.0% shares | Q2 2026 |
| Birchview Capital, LPWealth manager | 2.7% | $5.8M | 178,110 | -15.2% shares | Q2 2026 |
| DAFNA Capital Management LLCHedge fund | 0.8% | $4.3M | 130,875 | +0.0% shares | Q2 2026 |
| Palo Alto Investors LPHedge fund | 0.4% | $2.8M | 84,631 | +0.0% shares | Q2 2026 |
| PSP Research LLCInstitutional asset manager | 0.2% | $234K | 9,000 | -25.0% shares | Q3 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 17). Screen STOK in the grand portfolio →
STOK stock trades by members of Congress
No member of Congress has disclosed a trade in STOK.
STOK questions and answers
Are insiders buying STOK stock?
Between Aug 1, 2026 and Oct 29, 2026, 3 STOK insiders filed 7 sales worth $1.1M on SEC Form 4, and no open-market purchases; 4 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own STOK?
18 13F filers hold STOK among their 50 largest positions, worth $899.3M combined, including Oleg Nodelman, James Flynn and Julian and Felix Baker. The biggest bets by portfolio weight are Lynx1 Capital Management LP (15.3%), Redmile Group, LLC (8.7%) and Troluce Capital Advisors LLC (6.1%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
Has Congress traded STOK?
No member of Congress has disclosed a trade in STOK.
Who is the largest holder of STOK?
Among 13F filers, Rtw Investments, LP reports the largest STOK position, $184.0M (5,623,525 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Lynx1 Capital Management LP's: 15.3% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.